BASF welcomes EU approval for zinc oxide
After BASF’s Tinosorb A2B, Z-Cote is the second nano UV filter to be approved for use in cosmetics in Europe.
BASF welcomes the official entry of zinc oxide into Annex VI of the EU Cosmetics Regulation. Zinc oxide — in both its nano and non-nano form — is now approved for use as a UV filter in cosmetics in Europe. “UV radiation is responsible for various physiological effects in the skin. These include sunburn, premature appearance of wrinkles and — with frequent intensive exposure — an increased risk of skin cancer,” said Dirk Mampe, Head of Business Management for Personal Care Specialties in Europe. “Each approval of a UV filter offers new options and a wider choice for formulators of sun care products to provide vital protection for the skin against these harmful effects of UV radiation. After the EU approval of Tinosorb A2B as the first nano UV filter in 2014, we now welcome the official entry of zinc oxide in its nano form into Annex VI of the EU Cosmetics Regulation.”
BASF offers zinc oxide product line under its Z-Cote brand
BASF offers zinc oxide — with and without coating — under its Z-Cote brand. The product line can be used for all kinds of formulations from skin care and sun care to decorative cosmetics. Both Z-Cote grades cover nearly the whole UV spectrum from the short UVB to the long UVA-I (380nm) wavelengths. “Particulate UV filters such as Z-Cote absorb, reflect and scatter UV light, depending on the size of the particles: the smaller the size, the higher the absorption. Whereas the scattering improves protection — especially in the long UVA-I wavelengths,” said Mampe. Z-Cote is specifically recommended for daily skin care and also suitable for the sensitive skin of children and people with allergies.
Zinc oxide also approved for the use in cosmetics in the US
In the personal care industry, zinc oxide is known for decades for its beneficial properties as skin protectant and its antimicrobial activity. Zinc oxide is one of only two UV filters approved for UVA1 protection in sun care applications in the US. All Z-Cote filters show synergistic effects with organic UV filters and can be used to enhance the UVA and SPF performance of a sunscreen product.
Two more UV filters ready for EU approval
The whole BASF range of UV filters has been toxicologically assessed for their suitability in cosmetic preparations. Nevertheless, the use of nano UV filters to protect the skin is still subject to specific legislation in many countries. For Europe, the next microfine UV filter is ready for approval: In February 2016, titanium dioxide has received a positive vote by the EU Commission Working Group on Cosmetics. The official entry of the nano UV filter into Annex VI of the EU Cosmetics Regulation is expected for the second half of 2016. With Methylene Bis-Benzotriazolyl Tetramethylbutyl-phenol (MBBT) another nano UV filter is still on the voting list of the EU. MBBT is on the market under the BASF brand Tinosorb M since 2000, when it got the approval as UV ingredient. Since then, it has been used worldwide — except the US — in sunscreens from pharmacy to store brands. However, a new approval as "nano“ was required due to the new EU Cosmetics Regulation. In 2015, the Scientific Committee for Consumer Safety (SCCS) published a positive scientific opinion on MBBT in nano form. The official entry into Annex VI is anticipated for 2017.
Related News
-
News PSCI Welcomes Delpharm, Samsung Biologics, and Suven as First Supplier Partners
The pharmaceutical industry continues to evolve with an increasing focus on responsible sourcing, sustainability, and collaboration across the supply chain. Under a new model to recognise suppliers within the pharmaceutical and healthcare industry that... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Eli Lilly's weight loss drugs removed from the FDA's shortage list
The US FDA have recently updated their drug shortage list. The recently released list shows that all dosage forms of Eli Lilly's weight-loss drug Zepbound and their diabetes drug Mounjaro are now available. -
News Global advancements in the diagnosis and treatment of rare diseases: Rare Disease Day 2024
Rare Diseases Day is celebrated on the 29th February 2024 and represents the plight of rare disease patients to gain diagnosis and access to suitable treatment. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance